Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
Mesoblast shares fell -4.45% in the first hour of trades on Tuesday as the company announced it has to resubmit an application to the FDA.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BNK | Ann: Estimated Annual Distribution Component Information | 08/07/24 | 0 | 58 | |||
|
|||||||
BNK | Ann: Units on Issue Disclosure - June 2024 | 04/07/24 | 0 | 74 | |||
|
|||||||
BNK | Ann: DRP Issue Price | 01/07/24 | 0 | 75 | |||
|
|||||||
BNK | Ann: Final Distribution Announcement | 01/07/24 | 0 | 68 | |||
|
|||||||
BNK | Ann: Estimated Distribution Announcement | 27/06/24 | 0 | 78 | |||
|
|||||||
BNK | Ann: Distribution Timetable | 24/06/24 | 0 | 81 | |||
|
|||||||
BNK | Ann: Units on Issue Disclosure - May 2024 | 07/06/24 | 0 | 73 | |||
|
|||||||
BNK | Ann: Units on Issue Disclosure - April 2024 | 06/05/24 | 0 | 81 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |